{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:28:08Z","timestamp":1791412088522,"version":"4.3.3"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113893","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T18:54:20Z","timestamp":1735066460000},"page":"113893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The total withanolides from the leaves of Datura stramonium L. Improves Alzheimer\u2019s disease pathology by restraining neuroinflammation through NLRP3\/IL-1\u03b2\/IL1R1\/TOM 1 pathway"],"prefix":"10.1016","volume":"146","author":[{"given":"Xinyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leixin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixue","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9165-3063","authenticated-orcid":false,"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113893_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102955","article-title":"Oxygen metabolism abnormality and Alzheimer's disease: an update","volume":"68","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2024.113893_b0010","doi-asserted-by":"crossref","first-page":"102846","DOI":"10.1016\/j.redox.2023.102846","article-title":"Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease","volume":"66","author":"Sangineto","year":"2023","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113893_b0015","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.3390\/molecules26123696","article-title":"Role of withaferin a and its derivatives in the management of alzheimer's disease: recent trends and future perspectives","volume":"26","author":"Das","year":"2021","journal-title":"Molecules."},{"issue":"2","key":"10.1016\/j.intimp.2024.113893_b0020","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health."},{"key":"10.1016\/j.intimp.2024.113893_b0025","unstructured":"Patterson, C., World Alzheimer report 2018. London: Alzheimer\u2019s Disease International, 2018."},{"issue":"3","key":"10.1016\/j.intimp.2024.113893_b0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of alzheimer's disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J Prev Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0035","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2850","article-title":"Amyloid-\u03b2 PET in Alzheimer's disease: A systematic review and Bayesian meta-analysis","volume":"13","author":"Ruan","year":"2023","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","article-title":"The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Wu","year":"2023","journal-title":"Eur J Med Res."},{"key":"10.1016\/j.intimp.2024.113893_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.intimp.2024.113893_b0050","doi-asserted-by":"crossref","first-page":"1257973","DOI":"10.3389\/fnagi.2023.1257973","article-title":"The efficacy and safety of anti-A\u03b2 agents for delaying cognitive decline in Alzheimer's disease: a meta-analysis","volume":"15","author":"Li","year":"2023","journal-title":"Front Aging Neurosci."},{"issue":"11","key":"10.1016\/j.intimp.2024.113893_b0055","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1002\/alz.14237","article-title":"Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies","volume":"20","author":"Tariot","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13195-018-0415-6","article-title":"Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study","volume":"10","author":"Timmers","year":"2018","journal-title":"Alzheimers Res Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.113893_b0065","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules27041210","article-title":"Amyloidosis in Alzheimer\u2019s disease: pathogeny, etiology, and related therapeutic directions","volume":"27","author":"Ma","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.intimp.2024.113893_b0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer's disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb Clin Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0075","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/s41598-024-66923-z","article-title":"Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform","volume":"14","author":"Agnello","year":"2024","journal-title":"Sci Rep."},{"issue":"18","key":"10.1016\/j.intimp.2024.113893_b0080","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.3390\/ijms231810831","article-title":"Biomarkers related to synaptic dysfunction to discriminate alzheimer's disease from other neurological disorders","volume":"23","author":"Piccoli","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113893_b0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2174\/1570159X18666201111104509","article-title":"Glia-Driven neuroinflammation and systemic inflammation in Alzheimer's disease","volume":"19","author":"Hashioka","year":"2021","journal-title":"Curr Neuropharmacol."},{"key":"10.1016\/j.intimp.2024.113893_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102229","article-title":"Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model","volume":"50","author":"Tang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2024.113893_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109070","article-title":"Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease","volume":"110","author":"Wang","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.113893_b0105","article-title":"Involvement of IL-10R\/STAT3 pathway in amyloid \u03b2 clearance by microlgia in Alzheimer's disease","volume":"101","author":"Liu","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113893_b0110","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113893_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3736\/jintegrmed2013016","article-title":"A review on the pharmacological and toxicological aspects of Datura stramonium L","volume":"11","author":"Martini","year":"2013","journal-title":"Integr Med."},{"key":"10.1016\/j.intimp.2024.113893_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110037","article-title":"Dihydromyricetin suppresses inflammatory injury in microglial cells to improve neurological behaviors of Alzheimer's disease mice via the TLR4\/MD2 signal","volume":"118","author":"Pei","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.113893_b0125","article-title":"\u03b1-linolenic acid mitigates microglia-mediated neuroinflammation of schizophrenia in mice by suppressing the NF-\u03baB\/NLRP3 pathway via binding GPR120-\u03b2-arrestin 2","volume":"142","author":"Hu","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113893_b0130","first-page":"643769","article-title":"Protein Trafficking or Cell Signaling: A Dilemma for the Adaptor Protein TOM 1. Front Cell","volume":"9","author":"Roach","year":"2021","journal-title":"Dev Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113893_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3736\/jintegrmed2013016","article-title":"A review on the pharmacological and toxicological aspects of Datura stramonium L","volume":"11","author":"Gaire","year":"2013","journal-title":"J Integr Med."},{"issue":"12","key":"10.1016\/j.intimp.2024.113893_b0140","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S2221-1691(13)60014-3","article-title":"Pharmacological properties of Datura stramonium L. as a potential medicinal tree: an overview. Asian Pac","volume":"2","author":"Soni","year":"2012","journal-title":"J Trop Biomed."},{"issue":"12","key":"10.1016\/j.intimp.2024.113893_b0145","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.bmc.2019.03.022","article-title":"Profiling withanolide A for therapeutic targets in neurodegenerative diseases","volume":"27","author":"Crane","year":"2019","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.intimp.2024.113893_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106394","article-title":"Withanolide-A treatment exerts a neuroprotective effect via inhibiting neuroinflammation in the hippocampus after pilocarpine-induced status epilepticus","volume":"165","author":"Zhu","year":"2020","journal-title":"Epilepsy Res."},{"issue":"10","key":"10.1016\/j.intimp.2024.113893_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105311","article-title":"Withanolide A prevents neurodegeneration by modulating hippocampal glutathione biosynthesis during hypoxia","volume":"9","author":"Baitharu","year":"2014","journal-title":"PLoS One."},{"issue":"8","key":"10.1016\/j.intimp.2024.113893_b0160","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","article-title":"The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson's disease","volume":"28","author":"Zhao","year":"2021","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.intimp.2024.113893_b0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19390211.2020.1741484","article-title":"Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects","volume":"18","author":"Mandlik Ingawale","year":"2021","journal-title":"J Diet Suppl."},{"issue":"23","key":"10.1016\/j.intimp.2024.113893_b0170","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1007\/s00018-015-2012-1","article-title":"Pharmacologic overview of Withania somnifera, the Indian Ginseng","volume":"72","author":"Dar","year":"2015","journal-title":"Cell Mol Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113893_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301655","article-title":"Cytotoxic withanolides from the leaves of Datura stramonium L","volume":"21","author":"Pan","year":"2024","journal-title":"Chem Biodivers."},{"key":"10.1016\/j.intimp.2024.113893_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.109010","article-title":"Four new withanolides with anti-inflammatory activity from Datura inoxia Mill. leaves","volume":"182","author":"Wu","year":"2022","journal-title":"Steroids."},{"issue":"4","key":"10.1016\/j.intimp.2024.113893_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300195","article-title":"Withanolides from physalin angulata and their inhibitory effects on nitric oxide production","volume":"20","author":"Tan","year":"2023","journal-title":"Chem Biodivers."},{"issue":"6","key":"10.1016\/j.intimp.2024.113893_b0190","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1248\/cpb.50.760","article-title":"Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities","volume":"50","author":"Zhao","year":"2002","journal-title":"Chem Pharm Bull (Tokyo)."},{"issue":"7","key":"10.1016\/j.intimp.2024.113893_b0195","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjp.0706122","article-title":"Neuritic regeneration and synaptic reconstruction induced by withanolide A","volume":"144","author":"Kuboyama","year":"2005","journal-title":"Br J Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113893_b0200","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/cbdv.200490091","article-title":"Cholinesterase-inhibiting withanolides from Ajuga bracteosa","volume":"1","author":"Riaz","year":"2004","journal-title":"Chem Biodivers."},{"issue":"11","key":"10.1016\/j.intimp.2024.113893_b0205","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1248\/cpb.52.1358","article-title":"Cholinesterase inhibiting withanolides from Withania somnifera","volume":"52","author":"Choudhary","year":"2004","journal-title":"Chem Pharm Bull (Tokyo)."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbrc.2005.06.086","article-title":"Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties","volume":"334","author":"Choudhary","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.intimp.2024.113893_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112598","article-title":"Euphorbia factor L2 alleviated gouty inflammation by specifically suppressing both the priming and activation of NLRP3 inflammasome","volume":"138","author":"Li","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113893_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110230","article-title":"SENP1 modulates chronic intermittent hypoxia-induced inflammation of microglia and neuronal injury by inhibiting TOM 1 pathway","volume":"119","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0230","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jep.2013.08.046","article-title":"Identification and analysis of absorbed components and their metabolites in rat plasma and tissues after oral administration of Ershiwuwei Shanhu' pill extracts by UPLC-DAD\/Q-TOF-MS","volume":"150","author":"Ying","year":"2013","journal-title":"J Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.113893_b0235","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jep.2015.04.039","article-title":"UPLC-Q-TOF\/MS-based screening and identification of the main flavonoids and their metabolites in rat bile, urine and feces after oral administration of Scutellaria baicalensis extract","volume":"169","author":"Du","year":"2015","journal-title":"J Ethnopharmacol."},{"issue":"53","key":"10.1016\/j.intimp.2024.113893_b0240","first-page":"2920","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","volume":"20","author":"Bromley-Brits","year":"2011","journal-title":"J Vis Exp."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0245","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.intimp.2024.113893_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154801","article-title":"Myricetin improves pathological changes in 3\u00d7Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway","volume":"115","author":"Liu","year":"2023","journal-title":"Phytomedicine."},{"key":"10.1016\/j.intimp.2024.113893_b0255","doi-asserted-by":"crossref","first-page":"1159657","DOI":"10.3389\/fendo.2023.1159657","article-title":"The therapeutic role and potential mechanism of EGCG in obesity-related precocious puberty as determined by integrated metabolomics and network pharmacology","volume":"14","author":"Gu","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"7","key":"10.1016\/j.intimp.2024.113893_b0260","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer's disease-pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.113893_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.003","article-title":"Inflammation in Alzheimer's disease: lessons learned from microglia-depletion models","volume":"61","author":"Spangenberg","year":"2017","journal-title":"Brain Behav Immun."},{"issue":"19","key":"10.1016\/j.intimp.2024.113893_b0270","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.3390\/ijms241914771","article-title":"Ursolic Acid Alleviates Neuroinflammation after Intracerebral Hemorrhage by Mediating Microglial Pyroptosis via the NF-\u03baB\/NLRP3\/GSDMD Pathway","volume":"24","author":"Lei","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.113893_b0275","doi-asserted-by":"crossref","first-page":"1552127","DOI":"10.1155\/2021\/1552127","article-title":"Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia\/Macrophage Pyroptosis through NF-\u03baB Suppression and NLRP3 Inflammasome Inhibition","volume":"2021","author":"Ran","year":"2021","journal-title":"Oxid Med Cell Longev."},{"key":"10.1016\/j.intimp.2024.113893_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.809433","article-title":"Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis","volume":"13","author":"Cai","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.intimp.2024.113893_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112469","article-title":"Olanzapine attenuates amyloid-\u03b2-induced microglia-mediated progressive neurite lesions","volume":"137","author":"Dongol","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113893_b0290","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/0929867323666160229113911","article-title":"Amyloid beta (A\u03b2) peptide and factors that play important roles in alzheimer's disease","volume":"23","author":"Jamasbi","year":"2016","journal-title":"Curr Med Chem."},{"issue":"1","key":"10.1016\/j.intimp.2024.113893_b0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13195-024-01504-w","article-title":"APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets","volume":"16","author":"Sirisi","year":"2024","journal-title":"Alzheimers Res Ther."},{"issue":"6","key":"10.1016\/j.intimp.2024.113893_b0305","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: a key regulator in alzheimer's disease progression and current development of its inhibitors","volume":"20","author":"Patel","year":"2022","journal-title":"Curr Neuropharmacol."},{"key":"10.1016\/j.intimp.2024.113893_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103006","article-title":"Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APPswe\/PS1dE9 mice","volume":"70","author":"Yang","year":"2024","journal-title":"Redox Biol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113893_b0315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0006-8993(01)02497-0","article-title":"Deposition of Alzheimer's vascular amyloid-beta is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB)","volume":"907","author":"Frackowiak","year":"2001","journal-title":"Brain Res."},{"issue":"13","key":"10.1016\/j.intimp.2024.113893_b0320","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2174\/1567205020666230203112351","article-title":"Roles of microglia in AD pathology","volume":"19","author":"Rong","year":"2023","journal-title":"Curr Alzheimer Res."},{"issue":"21","key":"10.1016\/j.intimp.2024.113893_b0325","doi-asserted-by":"crossref","first-page":"12990","DOI":"10.3390\/ijms232112990","article-title":"Microglia and Alzheimer's disease","volume":"23","author":"Merighi","year":"2022","journal-title":"Int J Mol Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:54:16Z","timestamp":1736614456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":64,"alternative-id":["S1567576924024159"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113893","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The total withanolides from the leaves of Datura stramonium L. Improves Alzheimer\u2019s disease pathology by restraining neuroinflammation through NLRP3\/IL-1\u03b2\/IL1R1\/TOM 1 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113893"}}